FDA Warns Cyberonics on Manufacturing  CHICAGO (Reuters) - U.S. regulators warned Cyberonics Inc.  of manufacturing deficiencies at the Houston plant that makes  its sole product, an implantable device to treat epilepsy, the  company said on Monday. 
What label best describes this news article? 